Zoetis Inc. (NYSE:ZTS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Zoetis Inc. has received a consensus recommendation of "Moderate Buy" from eight research firms, with four rating it as a hold and four as a buy.
• The stock's average 12-month price target among brokerages is $202.43, following various analysts adjusting their target prices.
• In the latest earnings report, Zoetis surpassed expectations with an EPS of $1.76, earning a net margin of 27.83% and a quarterly revenue of $2.46 billion.

Shares of Zoetis Inc. (NYSE:ZTS - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the eight research firms that are covering the stock, MarketBeat reports. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $202.4286.

A number of research firms have commented on ZTS. Piper Sandler lifted their target price on shares of Zoetis from $210.00 to $215.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. Leerink Partners lowered shares of Zoetis from an "outperform" rating to a "market perform" rating and lowered their target price for the stock from $180.00 to $155.00 in a report on Thursday, July 17th. Stifel Nicolaus lowered shares of Zoetis from a "buy" rating to a "hold" rating and lowered their target price for the stock from $165.00 to $160.00 in a report on Wednesday, June 18th. UBS Group lowered their target price on shares of Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Finally, Leerink Partnrs lowered shares of Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th.

Zoetis Stock Performance

Shares of Zoetis stock opened at $155.12 on Wednesday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. The firm has a market cap of $68.75 billion, a P/E ratio of 26.70, a P/E/G ratio of 2.49 and a beta of 0.88. The firm has a 50 day simple moving average of $153.53 and a 200 day simple moving average of $158.28. Zoetis has a fifty-two week low of $139.70 and a fifty-two week high of $200.33.

Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The firm had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the previous year, the business earned $1.56 EPS. The business's quarterly revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts predict that Zoetis will post 6.07 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Roxanne Lagano sold 652 shares of the business's stock in a transaction on Tuesday, June 3rd. The shares were sold at an average price of $170.00, for a total value of $110,840.00. Following the completion of the transaction, the executive vice president owned 15,129 shares of the company's stock, valued at $2,571,930. The trade was a 4.13% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.16% of the stock is owned by company insiders.

Hedge Funds Weigh In On Zoetis

Institutional investors and hedge funds have recently made changes to their positions in the company. Portside Wealth Group LLC grew its holdings in shares of Zoetis by 24.7% in the 1st quarter. Portside Wealth Group LLC now owns 33,709 shares of the company's stock valued at $5,550,000 after buying an additional 6,672 shares during the period. Tandem Investment Advisors Inc. grew its holdings in shares of Zoetis by 100.3% in the 1st quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company's stock valued at $65,140,000 after buying an additional 198,089 shares during the period. Flagship Harbor Advisors LLC grew its holdings in shares of Zoetis by 31.2% in the 1st quarter. Flagship Harbor Advisors LLC now owns 7,394 shares of the company's stock valued at $1,217,000 after buying an additional 1,760 shares during the period. Horizon Financial Services LLC acquired a new position in shares of Zoetis in the 1st quarter valued at $380,000. Finally, Sage Rhino Capital LLC lifted its position in Zoetis by 117.6% in the 1st quarter. Sage Rhino Capital LLC now owns 7,014 shares of the company's stock valued at $1,155,000 after acquiring an additional 3,791 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.